Steardo L - Search Results

1

CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor.

Trabace L, Cassano T, Loverre A, Steardo L, Cuomo V. Trabace L, et al. Among authors: steardo l. CNS Drug Rev. 2002 Spring;8(1):53-69. doi: 10.1111/j.1527-3458.2002.tb00215.x. CNS Drug Rev. 2002. PMID: 12070526 Free PMC article. Review.

2

Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study.

Trabace L, Cassano T, Colaianna M, Castrignanò S, Giustino A, Amoroso S, Steardo L, Cuomo V. Trabace L, et al. Among authors: steardo l. Pharmacol Res. 2007 Oct;56(4):288-94. doi: 10.1016/j.phrs.2007.07.006. Epub 2007 Jul 27. Pharmacol Res. 2007. PMID: 17822918

3

Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.

Trabace L, Cassano T, Steardo L, Pietra C, Villetti G, Kendrick KM, Cuomo V. Trabace L, et al. Among authors: steardo l. J Pharmacol Exp Ther. 2000 Jul;294(1):187-94. J Pharmacol Exp Ther. 2000. PMID: 10871311

4

Effects of ENA713 and CHF2819, two anti-Alzheimer's disease drugs, on rat amino acid levels.

Trabace L, Cassano T, Cagiano R, Tattoli M, Pietra C, Steardo L, Kendrick KM, Cuomo V. Trabace L, et al. Among authors: steardo l. Brain Res. 2001 Aug 10;910(1-2):182-6. doi: 10.1016/s0006-8993(01)02653-1. Brain Res. 2001. PMID: 11489269

5

Genetic factors involved in the effects of developmental low-level alcohol induced behavioral alterations in rats.

Cagiano R, Cassano T, Coluccia A, Gaetani S, Giustino A, Steardo L, Tattoli M, Trabace L, Cuomo V. Cagiano R, et al. Among authors: steardo l. Neuropsychopharmacology. 2002 Feb;26(2):191-203. doi: 10.1016/S0893-133X(01)00306-2. Neuropsychopharmacology. 2002. PMID: 11790515

6

Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects.

Costa LG, Steardo L, Cuomo V. Costa LG, et al. Among authors: steardo l. Pharmacol Rev. 2004 Mar;56(1):103-47. doi: 10.1124/pr.56.1.5. Pharmacol Rev. 2004. PMID: 15001664 Review.

7

The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: an in vivo microdialysis study in the awake rat.

Trabace L, Cassano T, Tucci P, Steardo L, Kendrick KM, Cuomo V. Trabace L, et al. Among authors: steardo l. Brain Res. 2004 May 22;1008(2):293-8. doi: 10.1016/j.brainres.2004.01.090. Brain Res. 2004. PMID: 15145769

8

Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring.

Antonelli T, Tomasini MC, Tattoli M, Cassano T, Tanganelli S, Finetti S, Mazzoni E, Trabace L, Steardo L, Cuomo V, Ferraro L. Antonelli T, et al. Among authors: steardo l. Cereb Cortex. 2005 Dec;15(12):2013-20. doi: 10.1093/cercor/bhi076. Epub 2005 Mar 23. Cereb Cortex. 2005. PMID: 15788701

9

Editorial: Dysmetabolism, Obesity, and Inflammation: Three Prominent Actors in the Drama of Major Neuropsychiatric Disorders.

Cassano T, Steardo L. Cassano T, et al. Among authors: steardo l. Front Neurosci. 2016 Aug 19;10:368. doi: 10.3389/fnins.2016.00368. eCollection 2016. Front Neurosci. 2016. PMID: 27594821 Free PMC article. No abstract available.

10

Selective activation of glutamate receptor NMDA subtype induces plasma vasopressin increase in rats.

Steardo L, Steardo MD, Mazzoccoli M, Testa N, Cuomo V. Steardo L, et al. Among authors: steardo md. Acta Neurol (Napoli). 1994 Dec;16(5-6):235-9. Acta Neurol (Napoli). 1994. PMID: 7709793

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page